Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines-Reference-Cited by-同舟云学术

Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines

Published:2015-10-09 Issue:11 Volume:22 Page:542-551
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Lorenzo C,Pérez-Chacón G,Garaulet G,Mallorquín Z,Zapata J M,Rodríguez A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt201553.pdf

Reference38 articles.

1. Ostrand-Rosenberg S . Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev 2008; 18: 11–18.

2. Malmberg KJ, Ljunggren HG . Escape from immune- and nonimmune-mediated tumor surveillance. Semin Cancer Biol 2006; 16: 16–31.

3. Chen DS, Mellman I . Oncology meets immunology: the cancer-immunity cycle. Immunity 2013; 39: 1–10.

4. Vignali DA, Kuchroo VK . IL-12 family cytokines: immunological playmakers. Nat Immunol 2012; 13: 722–728.

5. Tahara H, Lotze MT . Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther 1995; 2: 96–106.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable hydrogel mediated delivery of gene-engineered adipose-derived stem cells for enhanced osteoarthritis treatment;Biomaterials Science;2021

2. Generation of a lentiviral vector system to efficiently express bioactive recombinant human prolactin hormones;Molecular and Cellular Endocrinology;2020-01

3. Intratumoral expression using a NFkB-based promoter enhances IL12 antitumor efficacy;Cancer Gene Therapy;2019-01-09

4. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters;Gene Therapy;2018-03-09

5. Antitumor Effects of IL-12 in Preclinical Studies;Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology;2016